BIMI
vs
S&P 500
BIMI
S&P 500
Over the past 12 months, BIMI has underperformed S&P 500, delivering a return of -95% compared to the S&P 500's +14% growth.
Stocks Performance
BIMI vs S&P 500
Performance Gap
BIMI vs S&P 500
Performance By Year
BIMI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bimi International Medical Inc
Glance View
BIMI International Medical, Inc. engages in the provision of healthcare products. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2010-10-04. The firm mainly conducts its businesses through four segments. The Wholesale Pharmaceutical segment provides prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The Wholesale Medical Device segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. The Medical Service segment include private comprehensive hospitals operating in China. The Retail Pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers.